Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.23% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Energy | 12.48% |
| 4 | Technology | 11.83% |
| 5 | Communication Services | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.67T
| $3.15B | 2.89% |
135,419,752
+9,377,528
| +7% | +$200M |
|
2
Alphabet (Google) Class C
GOOG
$4.19T
| $2.82B | 2.59% |
97,653,754
-7,248,618
| -7% | -$197M |
|
3
Mastercard
MA
$521B
| $2.29B | 2.1% |
31,166,971
-136,338
| -0.4% | -$10.1M |
|
|
4
SLB Ltd
SLB
$85.1B
| $2.02B | 1.86% |
17,150,266
+4,469,891
| +35% | +$461M |
|
5
Biogen
BIIB
$32.3B
| $1.98B | 1.82% |
6,280,884
-56,269
| -0.9% | -$16.9M |
|
6
Meta Platforms (Facebook)
META
$1.47T
| $1.98B | 1.82% |
29,407,983
+1,093,036
| +4% | +$67.2M |
|
7
Amazon
AMZN
$2.87T
| $1.84B | 1.69% |
113,522,740
-6,632,340
| -6% | -$105M |
|
8
Booking.com
BKNG
$155B
| $1.63B | 1.5% |
33,968,600
+1,248,000
| +4% | +$59.9M |
|
|
MON
9
DELISTED
Monsanto Co
MON
| $1.54B | 1.42% |
12,359,220
-794,404
| -6% | -$93M |
|
|
CXO
10
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.34B | 1.24% |
9,303,408
-89,221
| -0.9% | -$11.8M |
|
11
Illumina
ILMN
$32.6B
| $1.34B | 1.23% |
7,721,160
+203,968
| +3% | +$30.4M |
|
12
Nike
NKE
$58.7B
| $1.31B | 1.2% |
33,724,848
-2,680,452
| -7% | -$99.7M |
|
13
Boeing
BA
$166B
| $1.3B | 1.2% |
10,246,991
+1,060,461
| +12% | +$138M |
|
14
Walt Disney
DIS
$187B
| $1.28B | 1.18% |
14,982,943
+722,284
| +5% | +$59M |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.27B | 1.17% |
8,148,246
-232,924
| -3% | -$36.8M |
|
16
Salesforce
CRM
$211B
| $1.26B | 1.16% |
21,765,669
+809,544
| +4% | +$43.7M |
|
17
Canadian Pacific Kansas City
CP
$82.7B
| $1.25B | 1.15% |
34,579,495
+1,199,150
| +4% | +$39.3M |
|
18
Visa
V
$712B
| $1.25B | 1.15% |
23,708,812
-292,172
| -1% | -$15.3M |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $1.25B | 1.15% |
14,530,799
+2,677,561
| +23% | +$204M |
|
|
NVO
20
Novo Nordisk
NVO
$202B
| $1.24B | 1.14% |
53,790,094
+719,596
| +1% | +$15.9M |
|
21
EOG Resources
EOG
$75.2B
| $1.19B | 1.09% |
10,150,658
+262,864
| +3% | +$27.6M |
|
|
PCP
22
DELISTED
PRECISION CASTPARTS CORP
PCP
| $1.18B | 1.09% |
4,680,745
+356,392
| +8% | +$91.1M |
|
23
Merck
MRK
$366B
| $1.15B | 1.06% |
20,826,920
-3,617,182
| -15% | -$197M |
|
24
Gilead Sciences
GILD
$181B
| $1.15B | 1.06% |
13,856,009
-2,059,749
| -13% | -$160M |
|
25
Bristol-Myers Squibb
BMY
$136B
| $1.15B | 1.06% |
23,675,401
-5,344,911
| -18% | -$263M |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Energy.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.